-
Cipla receives USFDA approval for Generic Abraxane
11 Apr 2025 05:07 GMT
… of Bristol Myers Squibb’s Abraxane® in the United States.
Cipla … is a therapeutic equivalent to Abraxane®, a widely used chemotherapy drug … or metastatic non-small cell lung cancer (NSCLC), and metastatic adenocarcinoma of …
-
Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Date of authorisation: 11/01/2008, Revision: 31, Status: Authorised
30 Jan 2025 17:24 GMT
… worse and survival. In contrast, Abraxane was more effective than conventional … metastatic adenocarcinoma of the pancreas, Abraxane was shown to improve overall … non-small cell lung cancer, 33% of patients receiving Abraxane and carboplatin responded …
-
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market
31 Jul 2024 22:56 GMT
… ;s and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed … cancer and non-small cell lung cancer (NSCLC), as well as a …
-
Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
14 Nov 2024 09:57 GMT
… cell lung cancer, and pancreatic carcinoma.6–8
Abraxane was … the analysis specifically targeted Abraxane-related effects.
Results … understand their association with Abraxane. Overall, these … -squamous non-small-cell lung cancer (IMpower130): a multicentre, …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … .
One example is Abraxane (nab-paclitaxel). When …
-
FDA approves new Bristol Myers drug for lung cancer
16 Nov 2023 21:00 GMT
… Myers Squibb’s new lung cancer medication Augtyro, which the … with non-small cell lung cancer have this alteration, and … Opdivo transformed the treatment of lung cancer. But for patients with … lived products like Revlimid, Abraxane and Eliquis hit or approach …
-
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
27 Sep 2023 03:17 GMT
… SoC -
Small Cell Lung Cancer Program
- Preliminary data from … onvansertib with SoC (Gemzar + Abraxane). In cohort 2, patients … initiated trials in small cell lung cancer (SCLC) and triple … -cancer-and-small-cell-lung-cancer-including-single-agent-activity- …
-
Bristol Myers Squibb Reports First Quarter Financial Results for 2025
24 Apr 2025 11:12 GMT
… on Revlimid, Pomalyst, Sprycel and Abraxane, as well as the impacts … )%
(43)%
(53)%
Abraxane
40
65
105
(72)% … of resectable non-small cell lung cancer at high risk of recurrence … )%
(43)%
(53)%
Abraxane
40
65
105
145
72 …
-
GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
10 Aug 2022 20:52 GMT
… of lung cancers are classified as non-small cell lung cancer (NSCLC … Abraxane resulted in significant downregulation of GNPNAT1 in lung cancer … Metastatic Ability of Lung Cancer Cells
GNPNAT1 mRNA … detected its function in lung cancer cells, and consequently …
-
Does US approval for key cancer drug make Cipla shares an attractive buy amid tariff concerns?
17 Apr 2025 08:24 GMT
… Earlier-than-expected approval for Abraxane is positive, but tariffs … recent approval of generic Abraxane could give Cipla a … metastatic non-small cell lung cancer, and metastatic adenocarcinoma of … US revenue from generic Abraxane for FY26. More importantly …
About
© 1995-2025